Litcius/Paper detail

Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer

Tzu‐Ting Huang, Erika J. Lampert, Cynthia Coots, Jungmin Lee

2020Cancer Treatment Reviews168 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOvarian cancerDNA damageCancer researchPI3K/AKT/mTOR pathwayOncologyTherapeutic windowDNACancerInternal medicinePharmacologyApoptosisGeneticsBiologyPARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentBRCA gene mutations in cancer
Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer | Litcius